Skip to main content

Market Overview

Markets
QQQ480.59
-5.34-1.10%
DIA409.65
-2.61-0.63%
SPY558.94
-4.57-0.81%
TLT86.69
-0.55-0.63%
GLD311.15
+4.271.39%

Joe Biden Rejects Certain Conditions Sought By 9/11 Defendants In Plea Negotiations

Share:
Joe Biden Rejects Certain Conditions Sought By 9/11 Defendants In Plea Negotiations

President Joe Biden has declined certain conditions proposed by lawyers representing defendants of the 9/11 attacks in possible plea negotiations, the Associated Press reported.

President Biden ruled out a presidential guarantee that the five defendants would be spared solitary confinement and receive trauma care from their CIA custody torture.

This decision leaves it up to the military prosecutors and defense lawyers to agree on a plea bargain. The proposed terms involve the five Guantanamo detainees pleading guilty and serving life sentences in exchange for avoiding the death penalty.

See Also: Mike Pence Was Offended By Ramaswamy’s Stance On 9/11, But The Candidate Still Doesn’t Believe Everything Government Told The Public

Lawyers from both sides have been attempting to resolve the case through negotiations and for Biden to oppose or support some of the conditions sought by the defense.

Turn Market Uncertainty Into Your Advantage

Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Join free for 7 days and trade alongside Matt in real time.

President Biden concurred with Defense Secretary Lloyd Austin‘s advice to reject the proposed negotiation terms. The President was reportedly uncomfortable with the idea of accepting plea terms from those responsible for one of the deadliest attacks on the U.S that led to the death of over 3,000 people.

Pretrial hearings have been ongoing at the U.S. military commission at Guantanamo Bay for over a decade, with no trial date set yet.

Read Next: Americans alone spend $100 billion on nicotine products per year. One startup has synthesized a medicine that eliminates the need to smoke in up to 95% of tested smokers. It's called Rexis Biotech and you can invest in it before the product's public release. Click here to see how.

Photo by Gints Ivuskans on Shutterstock


Engineered by Benzinga Neuro, Edited by
Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
Learn more.


Trading Expert Matt Maley's Natural Gas Strategy

The Wall Street veteran's technical analysis of natural gas helped members capture gains on UNG calls. His recent alert delivered a 175% gain—with clear guidance on exactly when to scale in and take profits. Each move is backed by technical signals Matt has used for decades on Wall Street. Get His Next Alert Free → Get The Next Alert Free →

 

Related Articles

View Comments and Join the Discussion!

Posted-In: 9/11 Joe BidenNews Politics General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com